CLDX - Celldex Therapeutics, Inc.
IEX Last Trade
25.74
0.150 0.583%
Share volume: 11,357
Last Updated: Thu 26 Dec 2024 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$25.59
0.15
0.59%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-02-28 | 2023-05-04 | 2023-08-08 | 2023-11-02 | 2024-02-26 | 2024-05-06 | |
| Total revenue | 163.000 K | 407.000 K | 1.613 M | 967.000 K | 268.000 K | 1.517 M | 4.131 M | 156.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 163.000 K | 407.000 K | 1.613 M | 967.000 K | 268.000 K | 1.517 M | 4.131 M | 156.000 K | |
| 149.69% | 296.31% | -40.05% | -72.29% | 466.04% | 172.31% | -96.22% | |||
| Operating expenses | 27.885 M | 28.103 M | 29.498 M | 33.438 M | 33.473 M | 42.756 M | 39.258 M | 40.764 M | |
| Selling general and admin | 7.154 M | 6.531 M | 6.599 M | 6.640 M | 7.221 M | 8.221 M | 8.832 M | 9.103 M | |
| Research and development | 20.731 M | 21.572 M | 22.899 M | 26.798 M | 26.252 M | 34.535 M | 30.426 M | 31.661 M | |
| Total expenses | 27.885 M | 28.103 M | 29.498 M | 33.438 M | 33.473 M | 42.756 M | 39.258 M | 40.764 M | |
| 0.78% | 4.96% | 13.36% | 0.10% | 27.73% | -8.18% | 3.84% | |||
| Operating income | -27.722 M | -27.696 M | -27.885 M | -32.471 M | -33.205 M | -41.239 M | -35.127 M | -40.608 M | |
| Ebit | -27.722 M | -27.696 M | -27.885 M | -32.471 M | -33.205 M | -41.239 M | -35.127 M | -40.608 M | |
| Pretax income | -36.004 M | -26.784 M | -26.487 M | -29.361 M | -30.502 M | -38.260 M | -43.306 M | -32.808 M | |
| -25.61% | -1.11% | 10.85% | 3.89% | 25.43% | 13.19% | -24.24% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -36.004 M | -26.784 M | -26.487 M | -29.361 M | -30.502 M | -38.260 M | -43.306 M | -32.808 M | |
| 25.61% | 1.11% | -10.85% | -3.89% | -25.43% | -13.19% | 24.24% | |||
| Net income | -36.004 M | -26.784 M | -26.487 M | -29.361 M | -30.502 M | -38.260 M | -43.306 M | -32.808 M | |
| 25.61% | 1.11% | -10.85% | -3.89% | -25.43% | -13.19% | 24.24% |